142 related articles for article (PubMed ID: 16084083)
1. Design, synthesis and structure-activity relationship of a series of fragment analogues of antistasin (ATS) and ghilantens (GLS).
Danalev DL; Vezenkov LT; Grigorova B
Bioorg Med Chem Lett; 2005 Oct; 15(19):4217-20. PubMed ID: 16084083
[TBL] [Abstract][Full Text] [Related]
2. Interaction of antistasin-related peptides with factor Xa: identification of a core inhibitory sequence.
Ohta N; Brush M; Jacobs JW
Thromb Haemost; 1994 Dec; 72(6):825-30. PubMed ID: 7740449
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of new analogues of antistasin.
Danalev DL; Vezenkov LT; Grigorova B
J Pept Sci; 2004 Jan; 10(1):27-36. PubMed ID: 14959889
[TBL] [Abstract][Full Text] [Related]
5. Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives.
Haginoya N; Kobayashi S; Komoriya S; Hirokawa Y; Furugori T; Nagahara T
Bioorg Med Chem Lett; 2004 Jun; 14(11):2935-9. PubMed ID: 15125963
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasin.
Mao SS; Przysiecki CT; Krueger JA; Cooper CM; Lewis SD; Joyce J; Lellis C; Garsky VM; Sardana M; Shafer JA
J Biol Chem; 1998 Nov; 273(46):30086-91. PubMed ID: 9804761
[TBL] [Abstract][Full Text] [Related]
7. Investigation of factor Xa inhibitors containing non-amidine S1 elements.
Franciskovich JB; Masters JJ; Tinsley JM; Craft TJ; Froelich LL; Gifford-Moore DS; Klimkowski VJ; Smallwood JK; Smith GF; Smith T; Towner RR; Weir LC; Wiley MR
Bioorg Med Chem Lett; 2005 Nov; 15(21):4838-41. PubMed ID: 16140530
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant efficacy and immunogenicity of the selective factor Xa inhibitor antistasin following subcutaneous administration in the rhesus monkey.
Dunwiddie CT; Nutt EM; Vlasuk GP; Siegl PK; Schaffer LW
Thromb Haemost; 1992 Mar; 67(3):371-6. PubMed ID: 1641828
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition.
Dunwiddie CT; Smith DE; Nutt EM; Vlasuk GP
Thromb Res; 1991 Dec; 64(6):787-94. PubMed ID: 1798970
[No Abstract] [Full Text] [Related]
10. Design, synthesis, and biological activity of non-basic compounds as factor Xa inhibitors: SAR study of S1 and aryl binding sites.
Komoriya S; Haginoya N; Kobayashi S; Nagata T; Mochizuki A; Suzuki M; Yoshino T; Horino H; Nagahara T; Suzuki M; Isobe Y; Furugoori T
Bioorg Med Chem; 2005 Jun; 13(12):3927-54. PubMed ID: 15911309
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of laminarin sulfates with anticoagulant activity.
Alban S; Kraus J; Franz G
Arzneimittelforschung; 1992 Aug; 42(8):1005-8. PubMed ID: 1418069
[TBL] [Abstract][Full Text] [Related]
12. Isolation and structural characterization of a potent inhibitor of coagulation factor Xa from the leech Haementeria ghilianii.
Condra C; Nutt E; Petroski CJ; Simpson E; Friedman PA; Jacobs JW
Thromb Haemost; 1989 Jun; 61(3):437-41. PubMed ID: 2572073
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Kunitz protease inhibitory domain of the amyloid beta-protein precursor as an anticoagulant in venovenous extracorporeal circulation in rabbits.
Annich G; White T; Damm D; Zhao Y; Mahdi F; Meinhardt J; Rebello S; Lucchesi B; Bartlett RH; Schmaier AH
Thromb Haemost; 1999 Nov; 82(5):1474-81. PubMed ID: 10595641
[TBL] [Abstract][Full Text] [Related]
14. A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech.
Faria F; Kelen EM; Sampaio CA; Bon C; Duval N; Chudzinski-Tavassi AM
Thromb Haemost; 1999 Nov; 82(5):1469-73. PubMed ID: 10595640
[TBL] [Abstract][Full Text] [Related]
15. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
Harenberg J; Giese C; Hagedorn A; Traeger I; Fenyvesi T
Semin Thromb Hemost; 2007 Jul; 33(5):503-7. PubMed ID: 17629847
[TBL] [Abstract][Full Text] [Related]
16. Demonstration that [A103,106,108] antistasin 93-119 inhibits the specific binding of antistasin to sulfatide [Gal(3-SO4)beta 1-1Cer].
Brankamp RG; Manley GD; Owen TJ; Krstenansky JL; Smith PL; Cardin AD
Biochem Biophys Res Commun; 1991 Nov; 181(1):246-51. PubMed ID: 1958194
[TBL] [Abstract][Full Text] [Related]
17. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
[TBL] [Abstract][Full Text] [Related]
18. Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors.
Nagata T; Yoshino T; Haginoya N; Yoshikawa K; Isobe Y; Furugohri T; Kanno H
Bioorg Med Chem Lett; 2007 Aug; 17(16):4683-8. PubMed ID: 17555959
[TBL] [Abstract][Full Text] [Related]
19. Ghilantens: anticoagulant-antimetastatic proteins from the South American leech, Haementeria ghilianii.
Brankamp RG; Blankenship DT; Sunkara PS; Cardin AD
J Lab Clin Med; 1990 Jan; 115(1):89-97. PubMed ID: 2299260
[TBL] [Abstract][Full Text] [Related]
20. Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site.
Dunwiddie C; Thornberry NA; Bull HG; Sardana M; Friedman PA; Jacobs JW; Simpson E
J Biol Chem; 1989 Oct; 264(28):16694-9. PubMed ID: 2777803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
